Related references
Note: Only part of the references are listed.Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma
Kathryn J. Brayer et al.
CANCER DISCOVERY (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
Livio Pagano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism
Pratiti Bandopadhayay et al.
NATURE GENETICS (2016)
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile
Lourdes Martin-Martin et al.
ONCOTARGET (2015)
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
J. Menezes et al.
LEUKEMIA (2014)
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition
M. R. Sapienza et al.
LEUKEMIA (2014)
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation
Damien Roos-Weil et al.
BLOOD (2013)
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
Jinghui Zhang et al.
NATURE GENETICS (2013)
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
Marta Persson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oncogenic mutations cause dramatic, qualitative changes in the transcriptional activity of c-Myb
F Liu et al.
ONCOGENE (2006)
Share Paper
